Health Canada’s wastewater monitoring report showed high levels of the flu in Manitoba as of Dec. 7, with samples from ...
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive topline results from the Phase ...
Discover the insights from the ET CIO virtual summit on 'Data & Analytics in the Agentic Era.' Learn how intelligent ...
The portfolio delivered a 1.90% net return in Q3 2025, driven by duration positioning and investment-grade corporate bonds.
As one of the battle captains assigned to the 101st Airborne Division (Air Assault), I was first struck by the amount of chat ...
Here are 11 free NPTEL data science and analytics courses from leading IITs cover graph theory, Bayesian modelling, Python, R ...
Patients should be selected for treatment with Enhertu in combination with pertuzumab based on confirmed HER2-positive status or HER2 gene amplification (IHC 3+ or ISH+).
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. (NYSE: PFE) today announced positive topline results from an interim analysis of the Phase 3 EV-304 ...
Follow-up results from the phase 3 EMBER-3 study showed that, as a monotherapy, Inluriyo demonstrated a 38% reduction in the ...
Contractor consolidation dominated the early 2020s. Now the money is flowing into equipment — pushed by the rise of data-center cooling.
Enhertu plus Perjeta is the first new first-line treatment for HER2-positive breast cancer in over a decade, approved by the ...
NASA’s Interstellar Mapping and Acceleration Probe (IMAP) mission has successfully captured its first light observations, ...